Whitaker repeated a call for “zero-for-zero” reciprocal tariffs between the U.S. and its trade partners in testimony before a ...

Vicarious Surgical and SS Innovations marked progress toward bringing their robotic surgery systems to the U.S. market. The ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

As a result of the restructuring, Embecta expects pretax savings between $7 million and $8 million during the second half of ...

By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that ...

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its ...

The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.

Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices ...

The company expects a tariff impact of up to 300 million euros, with the biggest hit from European goods going to the U.S.

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

The maker of patient monitoring devices is working to bring the affected portions of its network back online and restore ...